Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
Widlak MM, Neal M, Daulton E, Thomas CL, Tomkins C, Singh B, Harmston C, Wicaksono A, Evans C, Smith S, Savage RS, Covington JA, Arasaradnam RP.
Widlak MM, et al. Among authors: savage rs.
Colorectal Dis. 2018 Dec;20(12):O335-O342. doi: 10.1111/codi.14431. Epub 2018 Oct 17.
Colorectal Dis. 2018.
PMID: 30248228
Clinical Trial.